- Bristol-Myers Continues to Show Bottoming Price Action on the Charts TheStreet.com
- Bristol-Myers Squibb, Celgene slide following news of delayed deal and psoriasis drug divestment CNBC
- Bristol-Myers Squibb Stock Is Falling as Celgene Deal Faces Setback Barron's
- Bristol-Myers Will Divest Celgene Blockbuster to Close Deal Yahoo Finance
- Bristol-Myers Stock Tumbles; Celgene Must Divest Psoriasis Drug Otezla Ahead Of Merger Investor's Business Daily
- View full coverage on Google News
by via Top stories - Google News
No comments:
Post a Comment